资讯库
更紧凑的生命科学资讯库。
先搜索，再按来源或主题继续收窄。
葛兰素史克旗下Tesaro与AnaptysBio因Jemperli协议对簿公堂
Some four years into Jemperli’s commercial life span, a rift has emerged between GSK subsidiary Tesaro and the potential cancer blockbuster’s original developer, Anapty...
先搜索，再按来源或主题继续收窄。
Some four years into Jemperli’s commercial life span, a rift has emerged between GSK subsidiary Tesaro and the potential cancer blockbuster’s original developer, Anapty...